Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
- PMID: 16921381
- DOI: 10.1038/ni1380
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
Abstract
Natural killer T (NKT) cells recognize glycosphingolipids presented by CD1d molecules and have been linked to defense against microbial infections. Previously defined foreign glycosphingolipids recognized by NKT cells are uniquely found in nonpathogenic sphingomonas bacteria. Here we show that mouse and human NKT cells also recognized glycolipids, specifically a diacylglycerol, from Borrelia burgdorferi, which causes Lyme disease. The B. burgdorferi-derived, glycolipid-induced NKT cell proliferation and cytokine production and the antigenic potency of this glycolipid was dependent on acyl chain length and saturation. These data indicate that NKT cells recognize categories of glycolipids beyond those in sphingomonas and suggest that NKT cell responses driven by T cell receptor-mediated glycolipid recognition may provide protection against diverse pathogens.
Comment in
-
NKT cells join the war on Lyme disease.Nat Immunol. 2006 Sep;7(9):904-6. doi: 10.1038/ni0906-904. Nat Immunol. 2006. PMID: 16924252 No abstract available.
Similar articles
-
Recognition of bacterial glycosphingolipids by natural killer T cells.Nature. 2005 Mar 24;434(7032):520-5. doi: 10.1038/nature03407. Nature. 2005. PMID: 15791257
-
Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells.Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1351-6. doi: 10.1073/pnas.0408696102. Epub 2005 Jan 21. Proc Natl Acad Sci U S A. 2005. PMID: 15665086 Free PMC article.
-
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.Nature. 2005 Mar 24;434(7032):525-9. doi: 10.1038/nature03408. Nature. 2005. PMID: 15791258
-
Application of natural killer T cells in antitumor immunotherapy.Crit Rev Immunol. 2007;27(6):511-25. doi: 10.1615/critrevimmunol.v27.i6.20. Crit Rev Immunol. 2007. PMID: 18197797 Review.
-
Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.Int Rev Immunol. 2007 Jan-Apr;26(1-2):73-94. doi: 10.1080/08830180601070252. Int Rev Immunol. 2007. PMID: 17454265 Review.
Cited by
-
Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice.Immunobiology. 2013 Apr;218(4):561-9. doi: 10.1016/j.imbio.2012.07.022. Epub 2012 Jul 27. Immunobiology. 2013. PMID: 22954709 Free PMC article.
-
The role of invariant natural killer T cells in microbial immunity.J Infect Chemother. 2013 Aug;19(4):560-70. doi: 10.1007/s10156-013-0638-1. Epub 2013 Jul 12. J Infect Chemother. 2013. PMID: 23846426 Free PMC article. Review.
-
The CD1 family: serving lipid antigens to T cells since the Mesozoic era.Immunogenetics. 2016 Aug;68(8):561-76. doi: 10.1007/s00251-016-0931-0. Epub 2016 Jul 2. Immunogenetics. 2016. PMID: 27368414 Free PMC article. Review.
-
Recognition of CD1d-restricted antigens by natural killer T cells.Nat Rev Immunol. 2012 Dec;12(12):845-57. doi: 10.1038/nri3328. Epub 2012 Nov 16. Nat Rev Immunol. 2012. PMID: 23154222 Free PMC article. Review.
-
Direct engagement of TLR4 in invariant NKT cells regulates immune diseases by differential IL-4 and IFN-γ production in mice.PLoS One. 2012;7(9):e45348. doi: 10.1371/journal.pone.0045348. Epub 2012 Sep 19. PLoS One. 2012. PMID: 23028952 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases